2022 annual financial data
Ligand Pharmaceuticals 2022 Operating margin
Ligand Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was 1.55%.
Operating income was 3,037,000 USD and net income was -33,361,000 USD.
Operating cash flow was 137,850,000 USD.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 196,245,000 USD
- Operating income
- 3,037,000 USD
- Net income
- -33,361,000 USD
- Operating cash flow
- 137,850,000 USD